112 related articles for article (PubMed ID: 16168296)
1. Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.
Monraats PS; Rana JS; Nierman MC; Pires NM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA; de Maat MP; Rittersma SZ; Schepers A; Doevendans PA; de Winter RJ; Tio RA; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Jukema JW
J Am Coll Cardiol; 2005 Sep; 46(6):1093-100. PubMed ID: 16168296
[TBL] [Abstract][Full Text] [Related]
2. The influence of established genetic variation in the haemostatic system on clinical restenosis after percutaneous coronary interventions.
Pons D; Monraats PS; de Maat MP; Pires NM; Quax PH; van Vlijmen BJ; Rosendaal FR; Zwinderman AH; Doevendans PA; Waltenberger J; de Winter RJ; Tio RA; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
Thromb Haemost; 2007 Dec; 98(6):1323-8. PubMed ID: 18064331
[TBL] [Abstract][Full Text] [Related]
3. Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.
Monraats PS; Pires NM; Agema WR; Zwinderman AH; Schepers A; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van Vlijmen BJ; Atsma DE; van der Laarse A; van der Wall EE; Jukema JW
Circulation; 2005 Oct; 112(16):2417-25. PubMed ID: 16230497
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and apoptosis genes and the risk of restenosis after percutaneous coronary intervention.
Monraats PS; de Vries F; de Jong LW; Pons D; Sewgobind VD; Zwinderman AH; de Maat MP; 't Hart LM; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Frants RR; van der Laarse A; van der Wall EE; Wouter Jukema J
Pharmacogenet Genomics; 2006 Oct; 16(10):747-54. PubMed ID: 17001294
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 10: a new risk marker for the development of restenosis after percutaneous coronary intervention.
Monraats PS; Kurreeman FA; Pons D; Sewgobind VD; de Vries FR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; Huizinga TW; Eefting D; Quax PH; Frants RR; van der Laarse A; van der Wall EE; Jukema JW
Genes Immun; 2007 Jan; 8(1):44-50. PubMed ID: 17122782
[TBL] [Abstract][Full Text] [Related]
6. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
Hitsumoto T; Takahashi M; Iizuka T; Shirai K
J Cardiol; 2006 Aug; 48(2):65-73. PubMed ID: 16948449
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha plays an important role in restenosis development.
Monraats PS; Pires NM; Schepers A; Agema WR; Boesten LS; de Vries MR; Zwinderman AH; de Maat MP; Doevendans PA; de Winter RJ; Tio RA; Waltenberger J; 't Hart LM; Frants RR; Quax PH; van Vlijmen BJ; Havekes LM; van der Laarse A; van der Wall EE; Jukema JW
FASEB J; 2005 Dec; 19(14):1998-2004. PubMed ID: 16319143
[TBL] [Abstract][Full Text] [Related]
8. Platelet receptor P2RY12 haplotypes predict restenosis after percutaneous coronary interventions.
Rudez G; Pons D; Leebeek F; Monraats P; Schrevel M; Zwinderman A; de Winter R; Tio R; Doevendans P; Jukema W; de Maat M
Hum Mutat; 2008 Mar; 29(3):375-80. PubMed ID: 18175333
[TBL] [Abstract][Full Text] [Related]
9. Candidate genetic markers and the risk of restenosis after coronary angioplasty.
Völzke H; Grimm R; Robinson DM; Wolff B; Schwahn C; Hertwig S; Motz W; Rettig R
Clin Sci (Lond); 2004 Jan; 106(1):35-42. PubMed ID: 12899665
[TBL] [Abstract][Full Text] [Related]
10. p27kip1-838C>A single nucleotide polymorphism is associated with restenosis risk after coronary stenting and modulates p27kip1 promoter activity.
van Tiel CM; Bonta PI; Rittersma SZ; Beijk MA; Bradley EJ; Klous AM; Koch KT; Baas F; Jukema JW; Pons D; Sampietro ML; Pannekoek H; de Winter RJ; de Vries CJ
Circulation; 2009 Aug; 120(8):669-76. PubMed ID: 19667240
[TBL] [Abstract][Full Text] [Related]
11. Fractalkine receptor polymorphisms V2491 and T280M as genetic risk factors for restenosis.
Niessner A; Marculescu R; Kvakan H; Haschemi A; Endler G; Weyand CM; Maurer G; Mannhalter C; Wojta J; Wagner O; Huber K
Thromb Haemost; 2005 Dec; 94(6):1251-6. PubMed ID: 16411402
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention.
Cho HJ; Chae IH; Park KW; Ju JR; Oh S; Lee MM; Park YB
J Hum Genet; 2002; 47(2):88-91. PubMed ID: 11916008
[TBL] [Abstract][Full Text] [Related]
13. Analysis of recurrent revascularization events following percutaneous coronary intervention of diabetic patients.
Anselmino M; Delcrè S; Moretti C; Biondi-Zoccai G; Omedè P; Sciuto F; Trevi GP; Sheiban I
Minerva Cardioangiol; 2009 Apr; 57(2):151-7. PubMed ID: 19274025
[TBL] [Abstract][Full Text] [Related]
14. [Associations between Ser447Ter gene polymorphism of lipoprotein lipase and atherosclerotic cerebral infarction].
Guan GD; Xu E; Wang XJ; Xu YH; Qiu SD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):519-22. PubMed ID: 17029199
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor: a new risk marker for clinical restenosis after percutaneous coronary intervention.
Monraats PS; Fang Y; Pons D; Pires NM; Pols HA; Zwinderman AH; de Maat MP; Doevendans PA; DeWinter RJ; Tio RA; Waltenberger J; Frants RR; Quax PH; van der Laarse A; van der Wall EE; Uitterlinden AG; Jukema JW
Expert Opin Ther Targets; 2010 Mar; 14(3):243-51. PubMed ID: 20095921
[TBL] [Abstract][Full Text] [Related]
16. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
[TBL] [Abstract][Full Text] [Related]
17. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
Blain JF; Aumont N; Théroux L; Dea D; Poirier J
Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549
[TBL] [Abstract][Full Text] [Related]
18. The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.
Talmud PJ; Flavell DM; Alfakih K; Cooper JA; Balmforth AJ; Sivananthan M; Montgomery HE; Hall AS; Humphries SE
Clin Sci (Lond); 2007 Jun; 112(12):617-24. PubMed ID: 17291198
[TBL] [Abstract][Full Text] [Related]
19. A novel bioresorbable polymer paclitaxel-eluting stent for the treatment of single and multivessel coronary disease: primary results of the COSTAR (Cobalt Chromium Stent With Antiproliferative for Restenosis) II study.
Krucoff MW; Kereiakes DJ; Petersen JL; Mehran R; Hasselblad V; Lansky AJ; Fitzgerald PJ; Garg J; Turco MA; Simonton CA; Verheye S; Dubois CL; Gammon R; Batchelor WB; O'Shaughnessy CD; Hermiller JB; Schofer J; Buchbinder M; Wijns W;
J Am Coll Cardiol; 2008 Apr; 51(16):1543-52. PubMed ID: 18420096
[TBL] [Abstract][Full Text] [Related]
20. The interleukin 1B-511 polymorphism is associated with the risk of developing restenosis after coronary stenting in Mexican patients.
Miranda-Malpica E; Martínez-Rios MA; Fragoso JM; Delgadillo-Rodríguez H; Rodríguez-Pérez JM; González-Quesada C; Martínez-Rodríguez N; Saldaña-Mendoza A; Peña-Duque MA; Vargas-Alarcón G
Hum Immunol; 2008 Feb; 69(2):116-21. PubMed ID: 18361937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
